Subscribe for great stories in your community!
King of Prussia’s CSL Behring has received more positive news for its autoimmune and inflammatory disease disorder drug Privigen, as the FDA has approved…
Paul Perreault, the 59-year-old chief executive officer and managing director of CSL Ltd., recently discussed with the Philadelphia Inquirer the effect that gene…
Before we send you to this site, please subscribe to our daily newsletter.